Kymera Therapeutics (KYMR) Return on Equity [ROE] (2020 - 2026)
Kymera Therapeutics' Return on Equity [ROE] came in at -22.97% for Q2 2026, up 12.51 percentage points from -35.48% a year earlier and up 0.06 percentage points from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Return on Equity [ROE] (2020 - 2026) Analysis & Trends
For FY2025, Kymera Therapeutics' Return on Equity [ROE] was -28.93%, up 13.59 percentage points from FY2024.
- Return on Equity [ROE] carries a five-year change of +15.28 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -42.52% in FY2024 (-5.12 pp), -37.40% in FY2023 (-3.45 pp), -33.96% in FY2022 (-6.91 pp) and -27.04% in FY2021 (+17.17 pp).
- The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] since Q4 2021.
- Year-over-year, Return on Equity [ROE] has increased for three consecutive quarters, with an average year-over-year change of +4.60 percentage points over the last eight quarters.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q3 2021 (a gain of 26.95 percentage points), and the weakest in Q3 2022 (a drop of 12.99 percentage points).
- Business Quant data shows KYMR's Return on Equity [ROE] at -23.03% (Q1 2026), -27.67% (Q4 2025) and -34.65% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Kymera Therapeutics | 11.66 Bn | 8.50 Bn | - | -23.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -23.41% |
| Jun 30, 2026 | -20.14% |
| Mar 31, 2026 | -20.46% |
| Dec 31, 2025 | -24.39% |
| Sep 30, 2025 | -30.82% |
| Jun 30, 2025 | -31.07% |
| Mar 31, 2025 | -29.49% |
| Dec 31, 2024 | -26.01% |
| Sep 30, 2024 | -20.67% |
| Jun 30, 2024 | -22.39% |
| Mar 31, 2024 | -27.72% |
| Dec 31, 2023 | -36.07% |
| Sep 30, 2023 | -39.47% |
| Jun 30, 2023 | -35.04% |
| Mar 31, 2023 | -33.37% |
| Dec 31, 2022 | -31.72% |
| Sep 30, 2022 | -35.05% |
| Jun 30, 2022 | -34.69% |
| Mar 31, 2022 | -28.60% |
| Dec 31, 2021 | -21.37% |
API Access
Kymera Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();